Amryt Pharma (Amryt Pharma) Book Value per Share : $5.07 (As of Sep. 2022)

View and export this data going back to 2019. Start your Free Trial

What is Amryt Pharma Book Value per Share?

Amryt Pharma's book value per share for the quarter that ended in Sep. 2022 was $5.07.

During the past 12 months, Amryt Pharma's average Book Value Per Share Growth Rate was 5.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 12 years, the highest 3-Year average Book Value Per Share Growth Rate of Amryt Pharma was 205.00% per year. The lowest was -19.40% per year. And the median was -1.20% per year.

Amryt Pharma's current price is $14.70. Its book value per share for the quarter that ended in Sep. 2022 was $5.07. Hence, today's PB Ratio of Amryt Pharma is 2.90.

During the past 12 years, the highest P/B Ratio of Amryt Pharma was 9.56. The lowest was 1.21. And the median was 2.49.

Amryt Pharma Book Value per Share Historical Data

The historical data trend for Amryt Pharma's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amryt Pharma Book Value per Share Chart

Amryt Pharma Annual Data

Trend

Mar12

Mar13

Mar14

Mar15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Book Value per Share

Get a 7-Day Free Trial

3.53

-0.40

4.31

1.85

5.58

Amryt Pharma Quarterly Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Book Value per Share	Get a 7-Day Free Trial															4.83	5.58	5.39	5.33	5.07

Competitive Comparison of Amryt Pharma's Book Value per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Amryt Pharma's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Amryt Pharma's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Amryt Pharma's PB Ratio distribution charts can be found below:

* The bar in red indicates where Amryt Pharma's PB Ratio falls into.

Amryt Pharma Book Value per Share Calculation

Amryt Pharma's Book Value Per Share for the fiscal year that ended in Dec. 2021 is calculated as:

Book Value Per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(356.7	-	0.0)	/	64.0
	=	5.58

Amryt Pharma's Book Value Per Share for the quarter that ended in Sep. 2022 is calculated as:

Book Value Per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(324.3	-	0.0)	/	64.0
	=	5.07

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.

Amryt Pharma (NAS:AMYT) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.

Amryt Pharma Book Value per Share Related Terms

Thank you for viewing the detailed overview of Amryt Pharma's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Amryt Pharma (Amryt Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amryt Pharma PLC (NAS:AMYT) » Definitions » Book Value per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

196 High Road, Dept 920A, Wood Green, London, GBR, N22 8HH

Website

http://www.amrytpharma.com

Amryt Pharma PLC is a specialty pharmaceutical company. It is focused on developing and delivering new treatments to help improve the lives of patients with rare or orphan diseases. It holds an exclusive license to sell Lojuxta (lomitapide) for adults, across the European Union and other territories including the Middle East, North Africa, Turkey and Israel. Lojuxta is used to treat a rare life-threatening disease called Homozygous Familial Hypercholesterolemia. Myalept (metreleptin) is an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients. It derives most of the revenue from the European Economic Area (EEA).